Doug Wright

“My conviction in ATS is stronger today than when and I joined the company. We participate in attractive markets with compelling long-term growth drivers. That, together with what I observed across the organization, reinforces my belief that we can, over time, operate above our stated operating margin target of 15%.”

“Today, ATS reported fourth quarter and annual results for fiscal 2026. For the full year, revenue and adjusted earnings from operations grew by approximately 11%, reflecting solid execution across the platform as our teams delivered innovative solutions to our global customer base.”

“I think half of our company align toward life sciences, and it's really an honor to be part of an organization that's really part of the development and support of some real life-changing therapies, whether it's in the GLP-1 class of products or in radio oncology or medical devices i think we're really in a great…”

“So while it's early, I do have a few observations that I'll share with the group. You know, first, I believe that we're aligned to strong and growing in markets in the portfolio and growth has been strong.”